Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
SAN FRANCISCO, Jan. 27, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in Fenix Parts Inc. (NASDAQ:FENX) of the March 13, 2017 Lead Plaintiff deadline in the securities class action filed in the U.S. District Court for the District of New Jersey.
If you purchased or otherwise acquired securities of FENX between May 14, 2015 and October 12, 2016 and suffered over $50,000 in losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/FENX
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
FENX disclosed on October 13, 2016 that it received a subpoena from the U.S. Securities and Exchange Commission. The SEC’s investigation appears to be focused on FENX changing its outside auditor, its previously announced business combinations and related goodwill impairment charges, the effectiveness of its internal controls over financial reporting and its valuation methodology.
Disclosure of this news drove the price of Fenix shares down approximately 11.6%.
“When the SEC identifies the breadth of accounting issues to investigate, as it did here, there is the potential for historical financial restatements,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding FENX should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
